Showing 151-160 of 334 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Investigating Combinatorial Use of Inhibitors of Focal Adhesion Kinase and PFKFB3 for Reversal of Type 1 Diabetes | Trustees of Indiana University | Jon Piganelli | Cures | 01-August-2023 to 30-June-2025 | $334,595.29 |
| Restoration of immune regulation in type 1 diabetes through the synergistic action of insulin-like growth factor-1 and interleukin-2 | University of Florida | Todd Brusko | Cures | 01-September-2024 to 31-August-2026 | $500,000.00 |
| Allogeneic hypoimmunogenic Pancreatic Islets for Treatment of Diabetes in the Intra-Muscular Site | The Regents of the University of California, San Francisco | Tobias Deuse | Cures | 01-August-2024 to 31-July-2026 | $799,998.40 |
| Achieving immune protection in islet transplantation by combining peptide-loaded nanoparticles with conformal coating of islets | University of Kansas Medical Center Research Institute, Inc. | Hubert Tse | Cures | 01-April-2024 to 31-March-2026 | $599,998.25 |
| Role of pericytes during type 1 diabetes pathogenesis | University of Miami | Luciana Mateus Goncalves | Cures | 01-March-2024 to 28-February-2027 | $259,750.00 |
| Endothelial cells for islet replacement in diabetes | Stanford University | Martin Neukam | Cures | 01-April-2024 to 31-March-2027 | $251,600.00 |
| Local delivery of immunomodulators to enable systemic immunosuppression-free efficient islet transplantation | The Regents of the University of California, San Francisco | Bhushan Kharbikar | Cures | 01-March-2024 to 28-February-2027 | $285,000.00 |
| Identifying regulators of primary human beta cell survival and proliferation | The Regents of the University of California, San Francisco | Rebecca Lee | Cures | 01-March-2024 to 28-February-2027 | $235,025.00 |
| Orthogonal engineering to suppress autoreactive T cell activation in T1D cell therapy | University of Florida | Jessie Barra | Cures | 01-March-2024 to 28-February-2027 | $285,000.00 |
| Localized delivery of costimulatory inhibitors and tolerogenic stromal cells for targeted immunomodulation in beta cell replacement | University of Miami | Alice Tomei | Cures | 01-February-2024 to 31-January-2027 | $750,000.00 |